focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

20 May 2011 16:16

RNS Number : 0399H
Maven Income & Growth VCT 4 PLC
20 May 2011
 



 

Maven Income and Growth VCT 4 PLC

 

Interim Management Statement

 

 

1. Net Asset Value

 

·; Ordinary share net asset value (NAV) Total Return of 115.0p per share and net asset value of 98.7p at 31 March 2011.

 

·; S Ordinary share NAV Total Return of 104.95p and NAV of 98.4p at 31 March 2011.

 

The NAVs shown above are unaudited and reflect the closing bid prices of quoted securities at 31 March 2011. Unlisted companies are normally valued on a six-monthly basis and the NAVs include the Directors' valuations of unlisted investments as at 31 December 2011 adjusted for material developments within the portfolios since that date.

 

2. Investments and disposals

 

During the quarter ended 31 March 2011, the Ordinary share portfolio invested £199,610 in private equity investments. During the same period, disposals generated aggregate proceeds of £486,380 against a cost of £372,444.

 

The S share portfolio invested £124,858 in private equity investments during the same period, and generated aggregate disposals proceeds of £145,450 against cost of £102,239.

 

There were no other material transactions during the period under review. 

 

3. Issue of shares

As previously announced, the Company has issued 431,672 Ordinary shares in respect of the Maven Linked VCT Offer 2.

4. Recent developments

Since 31 March 2011, the Ordinary share portfolio has invested £86,000 in Torridon Capital, which supplies legal and financial insurance products and litigation services. The S share portfolio invested £73,000 in the same company.

 

Further disposals generated proceeds of £4,080 for the Ordinary share portfolio against costs of £3,044.

 

The Board is not aware of any other events or transactions that have taken place between 31 March 2011 and the date of publication of this statement and which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

 

20 May 2011

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSURAVRAOAVUAR
Date   Source Headline
1st Oct 201912:34 pmRNSNet Asset Value(s)
20th Sep 201912:44 pmRNSHalf-year Report
19th Sep 20193:46 pmRNSTransaction in Own Shares
17th Sep 20193:00 pmRNSTransaction in Own Shares
28th Aug 20192:59 pmRNSStatement re Possible Merger
27th Aug 20194:38 pmRNSStatement re NAV and Interim Dividend
23rd Aug 20194:23 pmRNSStatement re Intended Joint Offer for Subscription
21st Aug 20194:14 pmRNSStatement re share premium account cancellation
21st May 20194:04 pmRNSTransaction in Own Shares
15th May 20195:02 pmRNSNet Asset Value(s)
15th May 20192:08 pmRNSResult of AGM
5th Apr 20193:25 pmRNSAnnual Financial Report
12th Mar 20192:52 pmRNSTransaction in Own Shares
28th Feb 20194:03 pmRNSNet Asset Value(s)
4th Dec 20184:42 pmRNSTransaction in Own Shares
27th Nov 20183:15 pmRNSTransaction in Own Shares
22nd Nov 20183:14 pmRNSTransaction in Own Shares
19th Nov 201811:45 amRNSDirector/PDMR Shareholding
19th Nov 201811:43 amRNSDirector/PDMR Shareholding
19th Nov 201811:40 amRNSDirector/PDMR Shareholding
15th Nov 20183:36 pmRNSDirectorate Change
15th Nov 20183:01 pmRNSMerger Update: Approval of Scheme
8th Nov 20184:27 pmRNSNet Asset Value(s)
1st Nov 201812:31 pmRNSResult of General Meeting
8th Oct 20187:00 amRNSStatement re Proposed Merger
14th Sep 20183:37 pmRNSHalf-year Report
13th Sep 20186:16 pmRNSPossible Merger
31st Aug 20184:04 pmRNSNet Asset Value(s)
22nd Jun 20184:30 pmRNSIssue of Equity
15th Jun 20184:47 pmRNSStatement re DIS
18th May 20184:47 pmRNSNet Asset Value(s)
17th May 20184:30 pmRNSDividend Declaration
15th May 20181:49 pmRNSResult of AGM
24th Apr 20184:52 pmRNSIssue of Equity
13th Apr 201812:48 pmRNSIssue of Equity
13th Apr 201811:59 amRNSPublication of Suppl.Prospcts
6th Apr 20184:41 pmRNSStatement re Dividend Investment Scheme
6th Apr 20184:34 pmRNSAnnual Financial Report
6th Apr 20189:23 amRNSDirector/PDMR Shareholding
6th Apr 20189:22 amRNSDirector/PDMR Shareholding
5th Apr 20186:23 pmRNSIssue of Equity
27th Mar 20185:44 pmRNSPublication of Suppl.Prospcts
8th Mar 20183:30 pmRNSDividend Declaration
6th Mar 20185:24 pmRNSTransaction in Own Shares
2nd Mar 201812:34 pmRNSStatement re Offer for Subscription
26th Feb 20184:25 pmRNSNet Asset Value(s)
6th Feb 20185:19 pmRNSDirector/PDMR Shareholding
6th Feb 20185:18 pmRNSDirector/PDMR Shareholding
6th Feb 20185:06 pmRNSIssue of Equity
24th Jan 20184:46 pmRNSPublication of Suppl.Prospcts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.